Your mission Contribution to multidisciplinary teams with own scientific expertise to achieve corporate and customer goals of challenging drug discovery projects within the field of insect cell culture You will be responsible for development, execution and optimization of expression strategies for recombinant protein production in insect cells with the goal to reach protein amounts and quality suitable for our structural studies (cryoEM, crystallography) Your main focus will be a high-throughput small- ( E.coli Preparation of all relevant project documentation (i.e. SOPs, technical reports, project plans, scientific presentations) will also be part of your work as well as their review and training Presentation of the scientific results as well as convincing and confident communication of the content to colleagues, customers and business partners Your profile Ph.D. in cell biology, pharmacology, biochemistry, or a related field, with a strong focus on membrane protein signaling. At least 3 years of experience in a drug discovery environment, covering the process from screening to lead identification. Deep understanding of GPCR pharmacology and G-protein interactions. Hands-on experience with FLIPR or FDSS workstations Proven expertise in other fluorescence- and luminescence-based GPCR assay technologies, such as TR-FRET, FRET, nanoBRET. Strong analytical and problem-solving skills with a high level of accuracy and attention to detail. Ability to work independently and in interdisciplinary teams across different projects. Why us? An innovative professional field in an exciting industry An inspiring working atmosphere as fertile ground for your further development A comprehensive induction that prepares you optimally for your area of responsibility Multicultural teams and an open corporate culture A salary in line with the market Contact Details Proteros biostructures GmbH People Team Bunsenstr. 7a, 82152 Martinsried 49 89 700761-0 joinusproteros.de About us Proteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros’ work is built on scientific excellence and supports its clients to reach the right results and accelerate their overall research timelines. Proteros supports most of the world’s 20 largest pharma companies and more than 250 pharmaceutical and biotech partners in the US, Europe and Japan.